Pricing Log in Create free account
Saturday 17 October 2026 Export COR’s income statement to Excel — free account

Cencora, Inc.

COR Healthcare Medical Distribution

Cencora, Inc.’s revenue for fiscal 2025 (year ended September 2025) was $321.3 billion, up 9.31% from fiscal 2024. In the quarter to June 2026, revenue grew 5.07%, EPS grew 11.3%, free cash flow grew 3,385.3% and total debt rose 42.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for three consecutive years, revenue growth for ten; insiders bought in the last twelve months.

340.66 0.75 −0.22%
Market cap
$65.2B
P/E
25.2×
Fwd P/E
14.5×
Dividend yield
0.70%
F-score
6/9
Altman Z
4.83
Beneish M
−2.54
Dividend safety
74/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Cencora, Inc. (COR) Operating cash flow

Alert me on Operating cash flow

Cencora, Inc.'s operating cash flow for fiscal 2025 was $3.9B, up 11.2% from $3.5B in fiscal 2024. Over the twelve months to 30 June 2026 it was $4.8B. Over the past ten years it has ranged from $1.4B (fiscal 2018) to $3.9B (fiscal 2015); the current reading is higher than 82% of that period. Cencora, Inc. ranks 3rd of 11 Medical Distribution companies by operating cash flow.

Operating cash flow, annual

Embed this chart

Annual newest first

Period Operating cash flow Change
FY2025 $3.9B 11.20%
FY2024 $3.5B (10.91%)
FY2023 $3.9B 44.70%
FY2022 $2.7B 1.37%
FY2021 $2.7B 20.82%
FY2020 $2.2B (5.84%)
FY2019 $2.3B 66.08%
FY2018 $1.4B (6.17%)
FY2017 $1.5B (52.68%)
FY2016 $3.2B (18.96%)

Quarterly newest first

Period Operating cash flow Change
Jun 2026 $2.7B 98.27%
Mar 2026 $1.3B —
Dec 2025 −$2.3B —
Sep 2025 $3.1B 2,768.20%
42 more quarters

Against its own ten years

Low $1.4B High $3.9B
Ten-year median $2.7B
Current reading's percentile 82

Operating cash flow against peers

Company Operating cash flow
MCK McKesson Corporation compare $6.9B
CAH Cardinal Health, Inc. compare $5.2B
COR Cencora, Inc. $4.8B
HSIC Henry Schein, Inc. compare $700.0M
AHG Akso Health Group Sponsored ADR compare $17.0M
HKPD Cellyan Biotechnology Co., Ltd compare $326.0K
COSM Cosmos Health Inc. compare −$9.8M
FOCL FocalTherics compare −$13.0M
ACH Accendra Health, Inc. compare −$180.4M

What Operating cash flow is

Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.

Reported line item

The full definition of Operating cash flow →

More on COR